Literature DB >> 30196964

Defining thresholds for abnormal premature progesterone levels during ovarian stimulation for assisted reproduction technologies.

Micah J Hill1, Mae Wu Healy2, Kevin S Richter3, Toral Parikh2, Kate Devine3, Alan H DeCherney2, Michael Levy3, Eric Widra3, George Patounakis2.   

Abstract

OBJECTIVE: To evaluate methodologies to establish abnormal progesterone (P) levels on the day of trigger for recommending freeze only cycles.
DESIGN: Threshold analysis and cost analysis.
SETTING: Private ART practice. PATIENT(S): Fresh autologous ART. INTERVENTIONS(S): None. MAIN OUTCOME MEASURE(S): Live birth. RESULT(S): Fourteen established statistical methodologies for generating clinical thresholds were evaluated. These methods were applied to 7,608 fresh ART transfer cycles to generate various P thresholds which ranged widely from 0.4 to 3.0 ng/mL. Lower thresholds ranged from 0.4 to 1 ng/mL and classified the majority of cycles as abnormal as well as required very large number needed to treat (NNT) to increase one live birth. Frozen embryo transfer was cost-effective when P was ≥1.5 ng/mL, with 12% of the population having an abnormal test result and an NNT of 13. Statistical and cost-effective thresholds clustered between 1.5 and 2.0 ng/mL. CONCLUSION(S): Statistically significant thresholds for P were demonstrated as low as 0.4 ng/mL but resulted in a very large NNT to increase one live birth. A clinical benefit to a freeze-only approach was demonstrated above P thresholds ranging from 1.5 to 2.0 ng/dL. At these thresholds, elevated P has a demonstrable and clinically significant negative effect and captures a smaller percentage of the patient population at higher risk for fresh transfer failure, thus making freeze-only a cost-effective option.
Copyright © 2018 American Society for Reproductive Medicine. All rights reserved.

Entities:  

Keywords:  IVF; Premature progesterone elevation; live birth; threshold analysis

Mesh:

Substances:

Year:  2018        PMID: 30196964     DOI: 10.1016/j.fertnstert.2018.05.007

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Serum progesterone level above 0.85 ng/mL and progesterone/estradiol ratio may be useful predictors for replacing cleavage-stage with blastocyst-stage embryo transfer in fresh IVF/ICSI cycles without premature progesterone elevation.

Authors:  Vehbi Yavuz Tokgoz; Ahmet Basar Tekin
Journal:  Arch Gynecol Obstet       Date:  2021-10-30       Impact factor: 2.344

2.  Common practices among consistently high-performing in vitro fertilization programs in the United States: 10-year update.

Authors:  Jennifer F Knudtson; Randal D Robinson; Amy E Sparks; Micah J Hill; T Arthur Chang; Bradley J Van Voorhis
Journal:  Fertil Steril       Date:  2021-10-18       Impact factor: 7.329

3.  The impact of preovulatory versus midluteal serum progesterone level on live birth rates during fresh embryo transfer.

Authors:  Abdelhamid Benmachiche; Sebti Benbouhedja; Abdelali Zoghmar; Peter Samir Hesjaer Al Humaidan
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

4.  Clinical pregnancy resulting from intracytoplasmic sperm injection of prematurely ovulated oocytes retrieved from the posterior cul-de-sac.

Authors:  Nigel Pereira; Pak H Chung; Isaac Kligman; Zev Rosenwaks
Journal:  F S Rep       Date:  2021-08-18

5.  EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays.

Authors:  N P Polyzos; E Anckaert; P Drakopoulos; H Tournaye; J Schiettecatte; H Donner; G Bobba; G Miles; W D J Verhagen-Kamerbeek; E Bosch
Journal:  J Endocrinol Invest       Date:  2020-03-13       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.